G. Toyokawa
Molecular Biology · 2011–2019
A researcher in the Science corpus: 16 papers; trusts 11 researchers and is trusted by 8 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 143 citations into it; #4,020 of 17,773 by trust here, #2,304 by citations
Whom G. Toyokawa trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- S. Hayami
- Masanori Yoshimatsu
- Hyun-soo Cho
- Ryuji Hamamoto
- John D. Kelly
- T. Jenuwein
- Yoichi Furukawa
- Takehiro Suzuki
- Tatsuhiko Tsunoda
- Yusuke Nakamura
Who trusts G. Toyokawa overall
- Hyun-soo Cho
- Ryuji Hamamoto
- Makoto Nakakido
- Takehiro Suzuki
- Lianhua Piao
- Yusuke Nakamura
- Zhenzhong Deng
- V. Saloura
- N. Dohmae
- Xiaolan Deng
Papers from G. Toyokawa's perspective
Ordered by how strongly the researchers G. Toyokawa trusts endorse each paper. Same corpus, a different order for every researcher.
- SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells
- Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. (Cell)
- Regulation of chromatin structure by site-specific histone H3 methyltransferases (Nature)
- Histone methylation in transcriptional control. (Current Opinion in Genetics and Development)
- Histone demethylation by a family of JmjC domain-containing proteins (Nature)
- Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins (Nature)
- The language of covalent histone modifications (Nature)
- SET Domain-containing Protein, G9a, Is a Novel Lysine-preferring Mammalian Histone Methyltransferase with Hyperactivity and Specific Selectivity to Lysines 9 and 27 of Histone H3* (Journal of Biological Chemistry)
- Genome-wide map of nucleosome acetylation and methylation in yeast. (Cell)
- Caught up in a Wnt storm: Wnt signaling in cancer. (Biochimica et Biophysica Acta)
Their papers
- Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers (2011) — 318 citations
- Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker (2011) — 190 citations
- Abstract 3019: Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells (2011) — 207 citations
- Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer (2011) — 114 citations
- Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1. (2011) — 120 citations
- Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression. (2012) — 179 citations
- Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase B (2012) — 120 citations
- RB1 methylation by SMYD2 enhances cell cycle progression through an increase of RB1 phosphorylation. (2012) — 196 citations
- Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway. (2011) — 100 citations
- The Histone Demethylase JMJD2B Plays an Essential Role in Human Carcinogenesis through Positive Regulation of Cyclin-Dependent Kinase 6 (2011) — 68 citations
- The histone methyltransferase Wolf–Hirschhorn syndrome candidate 1‐like 1 (WHSC1L1) is involved in human carcinogenesis (2013) — 67 citations
- A Positive Correlation Between the EZH2 and PD-L1 Expression in Resected Lung Adenocarcinomas. (2019) — 34 citations
- Prevalence of Enhancer of Zeste Homolog 2 in Patients with Resected Small Cell Lung Cancer (2018) — 12 citations
- The Prognostic Impact of Jumonji Domain-containing 2B in Patients with Resected Lung Adenocarcinoma. (2016) — 10 citations
- SMYD2-dependent HSP90 methylation promotes cancer cell proliferation by regulating the chaperone complex formation. (2014) — 93 citations
- The JmjC domain‐containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene (2012) — 96 citations